Skip to main content
SpringerLink
Log in

Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

The effects of angiotensin converting enzyme inhibitors (ACEI) on proteinuria, renal function, and serum proteins were evaluated in six children with steroid-resistant nephrotic syndrome and proteinuria of 3–15 g/24h (277±47 mg/m2 per hour). Following ACEI, proteinuria decreased from 7,408±2,385 (mean±SEM) to 3,746±1,395 mg/24 h (P<0.05). Creatinine clearance was 87.8±22.6 before and 96.4±23.6 ml/min per 1.73 m2 after ACEI. In two patients, inulin and para-aminohippuric acid clearances were normal before and after ACEI, together with parallel reductions of urine protein of 50% and 46%. Clearance of total protein was reduced by 56% following ACEI, compared with reduction in the clearance of gamma globulin by 58% and albumin by 39.5%. No significant change was seen in blood pressure, serum albumin, or total protein following ACEI. After ACEI, diuretic doses were able to be reduced or eliminated in three patients. Reduction of proteinuria was sustained during a followup period of 11–20 months in three patients. ACEI may be of benefit in the clinical management of children with steroidresistant nephrotic syndromes, allowing reduction in diuretic requirements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bernard DB (1988) Extrarenal complications of the nephrotic syndrome. Kidney Int 33: 1184–1202

    Google Scholar 

  2. Velosa JA, Holley KE, Torres VE, Offord KP (1983) Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clin Proc 58: 568–577

    Google Scholar 

  3. Beaufils H, Alphonse JC, Guedon J, Legrain M (1978) Focal glomerulosclerosis: natural history and treatment: a report of 70 cases. Nephron 21: 75–85

    Google Scholar 

  4. Korbet SM, Schwartz MM, Lewis EJ (1986) The prognosis of focal segmental glomerular sclerosis of adulthood. Medicine 65: 304–311

    Google Scholar 

  5. Whelton A, Stout RL, Spilman PS, Klassen DK (1990) Renal effects of ibuprofen, priroxicam, and sulindac in patients with asymptomatic renal failure. Ann Intern Med 112: 568–576

    Google Scholar 

  6. Walser M (1990) Progression of chronic renal failure in man. Kidney Int 37: 1195–1210

    Google Scholar 

  7. Abraham PA, Opsahl JA, Halstenson CE, Keane WF (1988) Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency. Arch Interm Med 148: 2358–2362

    Google Scholar 

  8. Mazzuca N, Bigazzi R, Paparatto P, Setti GP, Valtriani C, Falciani C, Chiapponi I, Bianchi S, Morini V, Baldari G (1988) Effects of enalapril on urinary protein excretion of essential and renal parenchymal hypertensive patients. J Nucl Med Allied Sci 32: 75–81

    Google Scholar 

  9. Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y (1985) Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313: 1617–1620

    Google Scholar 

  10. Kisch ES (1987) Captopril and proteinuria in diabetes mellitus. Isr J Med Sci 23: 833–834

    Google Scholar 

  11. Lagrue G, Robeva R, Laurent J (1987) Antiproteinuric effect of captopril in primary glomerular disease. Nephron 46: 99–100

    Google Scholar 

  12. Keane WF, Anderson S, Aurell M, Zeeuw D de, Narins RG, Povar G (1989) Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Ann Intern Med 111: 503–516

    Google Scholar 

  13. Trachtman H, Gauthier B (1988) Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease. J Pediatr 112: 295–298

    Google Scholar 

  14. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–265

    Google Scholar 

  15. Duarte CG, Elveback LR, Liedtke RR (1980) Glomerular filtration rate and renal plasma flow. In: Duarte CG, Boston MD (eds) Renal function tests: clinical laboratory procedures and diagnosis. Little, Brown, Boston, pp 29–47

    Google Scholar 

  16. Anderson S, Brenner BM (1987) Therapeutic implications of converting-enzyme inhibitors in renal disease. Am J Kidney Dis 10: 81–87

    Google Scholar 

  17. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G (1990) Angiotenin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85: 541–549

    Google Scholar 

  18. Heeg JE, Jong PE de, Van Der Hem GK, Zeeuw D de (1987) Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 32: 78–83

    Google Scholar 

  19. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM (1988) Mechanisms underlying transition from acute glomerular injury to glomerulosclerosis in a rat model of nephrotic syndrome. J Clin Invest 82: 1757–1768

    Google Scholar 

  20. Meyer TW, Anderson S, Rennke HG, Brenner BM (1987) Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 31: 752–759

    Google Scholar 

  21. Yoshioka T, Mitarai T, Kon V, Deen WM, Rennke HG, Ichikawa I (1986) Role for angiotensin-II in overt proteinuria. Kidney Int 30: 538–545

    Google Scholar 

  22. Schuster VL, Kokko JP, Jacobsen HR (1984) Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Invest 73: 507–515

    Google Scholar 

  23. Harris PJ, Navar LG (1985) Tubular transport responses to angiotensin. Am J Physiol 248: F621-F630

    Google Scholar 

  24. Liu FY, Cogan MG (1987) Angiotensin II. A potent regulator of acidification in the rat early proximal convoluted tubule. J Clin Invest 80: 273–275

    Google Scholar 

  25. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ (1990) In situ hybridization evidence for antiotensinogen messenger RNA in the rat proximal tubule. J Clin Invest 85: 417–423

    Google Scholar 

  26. Taugner RF, Hackenthal E, Rix E, Nobiling R, Paulsen K (1987) Immunocytochemistry of the renin angiotensin system: renin, angiotensinogen, angiotensin I, angiotensin II, and converting enzyme in the kidneys of mice, rats, and tree shrews. Kidney Int 22: S33-S43

    Google Scholar 

  27. Ingelfinger J, Anderson S, Hirsch A, Bouyounes B, Brenner BM (1990) Renal angiotensin converting enzyme (ACE) activity is related to degree of proteinuria in active puromycin nephrosis (PAN). Pediatr Res 27: 330A

    Google Scholar 

  28. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925–1930

    Google Scholar 

  29. Hostetter HT, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the indication and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380

    Google Scholar 

  30. Brenner BM, Meyer TW, Hostether TH (1982) Dietary protein intake and progressive nature of kidney disease: the role of hemodynamically mediated injury in the pathogenesis of progressive glomerular sclerosing in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307: 652–659

    Google Scholar 

  31. Fitzwater DS, Brouhard BH, Cunningham RJ (1990) Use of angiotensin converting enzyme inhibitors for the treatment of focal segmental glomerulosclerosis. Am J Dis Child 144: 522

    Google Scholar 

  32. Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M (1986) Beneficial effect of angiotensin converting enzyme inhibitor on renal function in patients with diabetic nephropathy. Br Med J 293: 471–474

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics and Division of Nephrology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA

    D. S. Milliner & B. Z. Morgenstern

Authors
  1. D. S. Milliner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Z. Morgenstern
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milliner, D.S., Morgenstern, B.Z. Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 5, 587–590 (1991). https://doi.org/10.1007/BF00856646

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00856646

Key words

Search

Navigation